You still haven't explained sales doing poorly when the exact opposite is the case. Pleeeeeeze explain. We're depending on your coming through on this.
Your podiatrist could get the same from nail clippings or bunion shaving. Your dentist from gum tissue. Your urologist from uretheoial cells, etc., etc., etc. have a cup of tea and chill,out -- but wash the cup when your done. Chaffed lips leave clues. Oh, and use latex gloves, but burn them after use since skin cells slough off. And, and this is very important, burn your mattress. It's probably filled with traces of you from rubbed off skin, etc. oh, and I forgot your shower drain. Just a small hidden sieve hidden in the drain and.....you're insurance toast.
REGARDING TODAY: Bearish with 2,381 puts trading, or 1.6x expected. Most active are Sep-16 17 puts and Sep-16 20 puts, with total volume in those strikes near 1,400 contracts.
Trovagene says BCBSIL to cover liquid biopsy tests
Trovagene announced that it has signed an in-network provider agreement with the healthcare network Blue Cross Blue Shield of Illinois establishing health benefit access to the full line of Trovagene's tests and services. The agreement with BCBSIL takes us a step further in the execution of our access and reimbursement strategy that includes establishing relationships with leading national and regional payors," said Bill Welch, CEO of Trovagene. "We are looking forward to offering oncologists and their patient's access to our Trovera urine and blood based liquid biopsy tests and enabling personalized cancer care." Trovagene now has contracts with payors covering approximately 168 million lives. Increasing patient access by contracting with payors is one of the critical strategic components that support the adoption of Trovagene's clinical testing in late-stage solid tumor cancers. Trovagene is up 4.8% to $5.86 in morning trading.
I've genuinely come to not trust management, Platinum and certainly not CRG. a Kline of credit as a safety facility makes sense. Why not secure it...for unforeseen issues, of which NAVB is plentiful.
I also do not understand or trut why MG said quite a while ago that money (2 mill) for MT was a "gift". That makes me VERY suspicious regarding potential unwinding S of the company, intended or not.
Pal: this still makes no sense to me. Mid want to line up a favorable line of credit NOW. Something not connecting here.
Kleeno: I have been happy w TROV too. It took a dive last week which was silly shorts and greed. They are actually growing in medical influence, with blood biopsy research, etc. We've got about #17,000 shares there.
I'd be interested to know if u have others in ur sights.
See news today re 62% insurance coverage is now in the bag. Very very good news. Here is a company w a quality project, management and service to human kind. I personally am On my way! Shorts being toasted. Shareholders are to want the long term good of a company and way too many do not. This management crosses all their T's in the right places as far as I can tell- RD, sales,,calculated risk, and eventual shareholder value.
Including a) clarification as to why liquid biopsy at this stage of development is NOT adequate for early colon cancer. Here Cologuard is THE test of choice.
Shorts should consider this: 11:31
BCBS of Illinois says Exact Sciences screening test may be considered necessary
In a pending medical policy with an effective date of August 15, BlueCross BlueShield of Illinois said that Exact Sciences' Cologuard stool DNA testing may be considered "medically necessary" for colorectal cancer screening once every 3 years for patients age 50-75 when certain criteria are met.
Boy Lupin has had a lot of patent infringement suits. Just google Lupin and patent suits....